The Effect of a Contingency Management Intervention on Substance Use
REAP
Effectiveness of Contingency Management in VA Addictions Treatment
1 other identifier
interventional
332
1 country
2
Brief Summary
Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2007
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2005
CompletedFirst Posted
Study publicly available on registry
November 11, 2005
CompletedStudy Start
First participant enrolled
May 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedResults Posted
Study results publicly available
August 29, 2014
CompletedAugust 16, 2018
July 1, 2018
2.7 years
November 9, 2005
August 18, 2014
July 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16
8 weeks
Secondary Outcomes (5)
Psychiatric Status
8 weeks, 6 months, 12 months
VHA Healthcare Service Utilization
Baseline to 6 month follow up and 6 month follow up to 12 month follow up.
Housing
8 week, 6 month and 12 month follow-ups
Legal Status
8 weeks, 6 month and 12 month follow ups
Employment Status
8 week, 6 month and 12 month follow up
Study Arms (2)
Contingency Management
EXPERIMENTALParticipants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are negative, they receive a chance to draw tokens from a bowl. Some tokens are social reinforcement. Others have monetary value.
Placebo
PLACEBO COMPARATORParticipants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.
Interventions
Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.
Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.
Eligibility Criteria
You may qualify if:
- veterans presenting for outpatient substance use disorders treatment with a diagnosis of alcohol, cocaine, amphetamine, or methamphetamine dependence
You may not qualify if:
- primary cannabis dependence
- primary opioid dependence
- severe psychiatric symptoms
- suicide risk
- positive history or screen for pathological gambling
- lacking transportation or living too far away to attend twice per week research appointments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417, United States
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108, United States
Related Publications (3)
Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, Kivlahan D. Rewarding early abstinence in Veterans Health Administration addiction clinics. J Subst Abuse Treat. 2013 Jul;45(1):109-17. doi: 10.1016/j.jsat.2013.01.006. Epub 2013 Feb 28.
PMID: 23453480RESULTHagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014 Jul 9;9(1):12. doi: 10.1186/1940-0640-9-12.
PMID: 25008457RESULTHagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. J Subst Abuse Treat. 2017 Aug;79:46-52. doi: 10.1016/j.jsat.2017.05.013. Epub 2017 May 25.
PMID: 28673526RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Hildi Hagedorn
- Organization
- Minneapolis VA Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Hildi J. Hagedorn, PhD
Minneapolis VA Health Care System, Minneapolis, MN
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2005
First Posted
November 11, 2005
Study Start
May 1, 2007
Primary Completion
January 1, 2010
Study Completion
February 1, 2010
Last Updated
August 16, 2018
Results First Posted
August 29, 2014
Record last verified: 2018-07